Using existing clinical trial data to proactively model patient safety and efficacy outcomes could aid in accelerating development for areas in need of new therapies.
Jonathan Peachey
Advertisement
Chief Operations Officer, Phesi
Articles by Jonathan Peachey
Phesi and Tufts CSDD share results from research on operating practices that can be improved.
Digital twins, defined as a typical demographic patient profile in a specific population, have the potential to help clinical trial design.
Analysis of 330,000 clinical trials calls for improved protocol design process.
Applied Clinical Trials
Case study shows that site activation is a key driver in determining patient enrollment cycle time, which can be minimized by identifying the "sweet spot" of sites to deploy for a clinical trial.
Applied Clinical Trials
Case study demonstrates that site activation is a key driver in determining patient enrollment cycle time.
Advertisement
Latest Updated Articles
Enrollment Cycle Times Can and Should Be OptimizedJanuary 17th 2018
- Enrollment Cycle Times Can and Should Be Optimized
January 17th 2018
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
ACT Brief: Real-Time Evidence Generation, Protocol Digitization, and Decentralized Trial Flexibility
2
Achieving Clinical Trial Success with Three Key Elements of eCOA User Acceptance Testing
3
Tapping the Global Potential of China’s Biotech Surge
4
2026 DIA Global Annual Meeting: How Structured Protocols Enable Automated Amendments and Real-Time FDA Oversight
5